BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2018
View Archived Issues
7 Hills Pharma receives support from NIH to develop next-generation integrin activator
Read More
Luye cleared for phase I trials in China with LY-03012
Read More
Cytokinetics presents data from phase II study of reldesemtiv
Read More
Novel collaborative agreement to develop Nanotaxi-formulated DNA dengue vaccine
Read More
Missense mutations in GLIS1 gene are linked to malformation syndromes
Read More
Phase II dose of BAL-101553 defined in solid tumors trial
Read More
GSX2 gene identified as causative of basal ganglia agenesis
Read More
Moxetumomab pasudotox pivotal trial data in relapsed/refractory hairy cell leukemia reported
Read More
Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome
Read More
Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs
Read More
New phase II trial studies arimoclomol for Gaucher's disease
Read More
Atossa completes dosing in phase I study of topical endoxifen
Read More
Immune Design opens phase III study of CMB-305 for synovial sarcoma
Read More
FDA approves use of Cinryze to prevent angioedema attacks in pediatric patients with HAE
Read More
PATH and SD Biosensor partner on new diagnostic for G6PD deficiency in malaria
Read More
Kiyatec initiates 3D-PREDICT study with EV3D assay
Read More
Xalud initiates phase I trial of XT-150 for osteoarthritic pain
Read More
TG Therapeutics and Novimmune enter global agreement to develop and commercialize TG-1801
Read More
Insights into the orthosteric and allosteric action of C5aR antagonists to guide drug development
Read More
Teijin Pharma presents CDK4/cyclin D3 and/or CDK6/cyclin D3 inhibitors
Read More
Amgen discovers apelin receptor agonists
Read More
MTHFD2 inhibitors identified at Daiichi Sankyo
Read More
Shanghai Meton Pharmaceutical patents NADP+ inhibitors
Read More